REGENXBIO Quarterly Balance Sheets Chart
Quarterly
|
Annual
REGENXBIO Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||||||||||||||
| current assets | ||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 79,558,000 | 130,104,000 | 57,526,000 | 56,617,000 | 57,765,000 | 112,975,000 | 34,522,000 | 53,045,000 | 68,600,000 | 70,091,000 | 96,952,000 | 118,544,000 | 121,374,000 | 191,873,000 | 345,209,000 | 228,387,000 | 257,072,000 | 291,482,000 | 338,426,000 | 93,220,000 | 94,222,000 | 69,411,000 | 69,514,000 | 79,594,000 | 55,142,000 | 55,852,000 | 75,561,000 | 142,423,000 | 106,889,000 | 71,870,000 | 46,656,000 | 59,884,000 | 57,649,000 | 82,045,000 | 24,840,000 | 28,108,000 | 30,083,000 | 35,511,000 | 54,116,000 | 205,324,000 |
| marketable securities | 243,740,000 | 137,765,000 | 177,161,000 | 198,843,000 | 232,592,000 | 225,728,000 | 240,736,000 | 248,842,000 | 251,482,000 | 261,726,000 | 267,690,000 | 263,874,000 | 281,588,000 | 202,261,000 | 112,230,000 | 111,473,000 | 117,665,000 | 149,398,000 | 137,314,000 | 148,305,000 | 174,964,000 | 209,846,000 | 226,696,000 | 252,125,000 | 286,354,000 | 229,373,000 | 244,200,000 | 230,166,000 | 179,605,000 | 157,997,000 | 114,122,000 | 106,778,000 | 104,434,000 | 63,764,000 | 64,714,000 | 63,662,000 | 64,124,000 | 65,544,000 | 60,025,000 | 8,025,000 |
| accounts receivable | 20,199,000 | 18,192,000 | 20,473,000 | 23,604,000 | 22,809,000 | 15,828,000 | 24,790,000 | 28,043,000 | 21,380,000 | 18,861,000 | 28,082,000 | 32,549,000 | 37,500,000 | 27,022,000 | 32,439,000 | 46,017,000 | 44,394,000 | 41,039,000 | 42,999,000 | 122,116,000 | 42,876,000 | 44,522,000 | 38,148,000 | 19,175,000 | 9,679,000 | 8,372,000 | 8,587,000 | 2,626,000 | 739,000 | 25,976,000 | 473,000 | 884,000 | 50,000 | 228,000 | 1,032,000 | 679,000 | 783,000 | 2,036,000 | ||
| prepaid expenses | 10,776,000 | 11,094,000 | 9,067,000 | 11,002,000 | 10,021,000 | 13,590,000 | 14,520,000 | 12,561,000 | 15,112,000 | 15,521,000 | 13,900,000 | 14,824,000 | 16,245,000 | 18,542,000 | 18,752,000 | 18,401,000 | 13,092,000 | 13,839,000 | 10,505,000 | 16,112,000 | 9,749,000 | 7,422,000 | 6,475,000 | 6,920,000 | 6,036,000 | 6,292,000 | 5,734,000 | 6,308,000 | 3,690,000 | 4,667,000 | 5,334,000 | 3,225,000 | 2,432,000 | 1,843,000 | 1,775,000 | 2,171,000 | 1,480,000 | 1,189,000 | 1,020,000 | 1,400,000 |
| other current assets | 19,479,000 | 16,082,000 | 13,774,000 | 23,330,000 | 23,496,000 | 27,297,000 | 20,403,000 | 23,347,000 | 22,235,000 | 23,003,000 | 9,352,000 | 6,848,000 | 8,717,000 | 7,179,000 | 10,196,000 | 5,886,000 | 5,164,000 | 2,880,000 | 1,953,000 | 7,197,000 | 7,271,000 | 7,032,000 | 4,199,000 | 2,414,000 | 2,281,000 | 3,995,000 | 3,831,000 | 4,834,000 | 2,347,000 | 2,208,000 | 1,412,000 | 1,390,000 | 1,252,000 | 922,000 | 1,010,000 | 2,000,000 | 1,437,000 | 1,300,000 | 851,000 | 127,000 |
| total current assets | 373,752,000 | 313,237,000 | 278,001,000 | 313,396,000 | 346,683,000 | 395,418,000 | 334,971,000 | 365,838,000 | 378,809,000 | 389,202,000 | 415,976,000 | 436,639,000 | 465,424,000 | 446,877,000 | 518,826,000 | 410,164,000 | 437,387,000 | 498,638,000 | 531,197,000 | 386,950,000 | 329,082,000 | 338,233,000 | 345,032,000 | 360,228,000 | 359,492,000 | 303,884,000 | 337,913,000 | 386,357,000 | 293,270,000 | 262,718,000 | 167,997,000 | 172,161,000 | 165,817,000 | 148,802,000 | 93,371,000 | 96,620,000 | 97,907,000 | 105,580,000 | 118,148,000 | 215,485,000 |
| property and equipment | 111,017,000 | 114,497,000 | 117,589,000 | 120,551,000 | 123,969,000 | 127,662,000 | 132,103,000 | 135,534,000 | 138,680,000 | 141,573,000 | 141,685,000 | 140,906,000 | 138,815,000 | 135,264,000 | 131,547,000 | 122,231,000 | 106,685,000 | 89,342,000 | 56,467,000 | 38,871,000 | 32,696,000 | 30,414,000 | 28,973,000 | 28,287,000 | 27,330,000 | 23,140,000 | 28,702,000 | 19,856,000 | 16,698,000 | 14,829,000 | 13,977,000 | 11,548,000 | 11,524,000 | 11,061,000 | 9,324,000 | 5,804,000 | 2,864,000 | 1,328,000 | 538,000 | 385,000 |
| operating lease right-of-use assets | 50,469,000 | 52,112,000 | 53,716,000 | 55,293,000 | 56,344,000 | 57,558,000 | 60,487,000 | 61,773,000 | 62,436,000 | 63,726,000 | 65,116,000 | 59,471,000 | 60,163,000 | 59,925,000 | 60,904,000 | 61,742,000 | 62,280,000 | 62,607,000 | 63,815,000 | 57,827,000 | 8,635,000 | 9,375,000 | 10,078,000 | 5,905,000 | 5,904,000 | 6,858,000 | ||||||||||||||
| restricted cash | 2,030,000 | 2,030,000 | 2,030,000 | 2,030,000 | 2,030,000 | 2,030,000 | 2,030,000 | 2,255,000 | 2,255,000 | 2,030,000 | 2,030,000 | 2,030,000 | 2,030,000 | 2,030,000 | 2,030,000 | 1,330,000 | 1,330,000 | 1,330,000 | 1,330,000 | 1,330,000 | 1,330,000 | 1,330,000 | 1,330,000 | 1,053,000 | 1,053,000 | 1,053,000 | 1,053,000 | 225,000 | 225,000 | 225,000 | 225,000 | 225,000 | 225,000 | 225,000 | 225,000 | 225,000 | 225,000 | |||
| other assets | 1,879,000 | 2,987,000 | 4,000,000 | 4,332,000 | 2,946,000 | 4,217,000 | 4,807,000 | 4,669,000 | 3,833,000 | 8,290,000 | 6,397,000 | 8,350,000 | 5,905,000 | 8,529,000 | 6,428,000 | 8,558,000 | 7,692,000 | 9,068,000 | 5,279,000 | 4,360,000 | 4,323,000 | 2,850,000 | 4,555,000 | 4,011,000 | 3,211,000 | 2,255,000 | 2,315,000 | 1,650,000 | 1,514,000 | 883,000 | 862,000 | 836,000 | 393,000 | 297,000 | 400,000 | 239,000 | 266,000 | 223,000 | 168,000 | 128,000 |
| total assets | 581,027,000 | 490,929,000 | 465,989,000 | 519,114,000 | 569,379,000 | 629,215,000 | 573,970,000 | 633,786,000 | 682,458,000 | 747,830,000 | 833,268,000 | 883,793,000 | 953,444,000 | 1,025,368,000 | 1,113,904,000 | 800,395,000 | 836,402,000 | 879,442,000 | 708,164,000 | 541,174,000 | 449,738,000 | 463,936,000 | 497,908,000 | 509,237,000 | 529,139,000 | 519,031,000 | 543,814,000 | 514,984,000 | 335,987,000 | 317,217,000 | 198,677,000 | 209,255,000 | 224,376,000 | 224,127,000 | 172,732,000 | 195,975,000 | 206,072,000 | 214,984,000 | 221,380,000 | 227,314,000 |
| liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||
| current liabilities | ||||||||||||||||||||||||||||||||||||||||
| accounts payable | 21,655,000 | 19,044,000 | 22,798,000 | 19,522,000 | 16,362,000 | 31,356,000 | 22,786,000 | 21,859,000 | 11,639,000 | 23,283,000 | 27,213,000 | 25,210,000 | 16,985,000 | 24,708,000 | 11,387,000 | 19,845,000 | 9,354,000 | 11,311,000 | 10,622,000 | 15,244,000 | 10,901,000 | 9,008,000 | 6,409,000 | 9,608,000 | 5,851,000 | 4,204,000 | 4,412,000 | 5,214,000 | 4,230,000 | 5,007,000 | 4,832,000 | 2,594,000 | 3,948,000 | 4,129,000 | 1,543,000 | 5,376,000 | 2,076,000 | 1,113,000 | 1,014,000 | 3,105,000 |
| accrued expenses and other current liabilities | 35,557,000 | 23,597,000 | 38,070,000 | 48,642,000 | 42,488,000 | 33,129,000 | 49,703,000 | 45,656,000 | 50,517,000 | 31,709,000 | 46,794,000 | 44,462,000 | 47,014,000 | 48,423,000 | 76,111,000 | 49,694,000 | 46,761,000 | 41,605,000 | 49,082,000 | 44,356,000 | 25,839,000 | 20,327,000 | 24,846,000 | 19,231,000 | 16,534,000 | 14,189,000 | 17,164,000 | 13,306,000 | 12,023,000 | 9,869,000 | 9,605,000 | 10,805,000 | 7,514,000 | 5,829,000 | 8,126,000 | 9,006,000 | 7,073,000 | 4,633,000 | 3,198,000 | |
| deferred revenue | 13,977,000 | 13,588,000 | 115,000 | 144,000 | 21,000 | 13,000 | 148,000 | 442,000 | 448,000 | 1,311,000 | 1,829,000 | 5,903,000 | 6,636,000 | 3,333,000 | 3,333,000 | 395,000 | 395,000 | 395,000 | 449,000 | 449,000 | 450,000 | 3,333,000 | 600,000 | 600,000 | 600,000 | 600,000 | ||||||||||||||
| operating lease liabilities | 8,049,000 | 7,942,000 | 7,902,000 | 7,720,000 | 7,302,000 | 7,066,000 | 7,068,000 | 6,639,000 | 6,326,000 | 6,303,000 | 5,997,000 | 3,608,000 | 2,832,000 | 2,121,000 | 1,752,000 | 1,329,000 | 1,709,000 | 1,843,000 | 2,500,000 | 3,564,000 | 3,013,000 | 2,454,000 | 2,421,000 | 2,506,000 | 2,276,000 | 2,397,000 | ||||||||||||||
| royalty monetization liabilities | 40,302,000 | |||||||||||||||||||||||||||||||||||||||
| total current liabilities | 119,540,000 | 106,731,000 | 103,194,000 | 102,725,000 | 98,273,000 | 110,179,000 | 130,272,000 | 127,346,000 | 117,893,000 | 112,334,000 | 130,434,000 | 123,548,000 | 114,556,000 | 119,937,000 | 130,472,000 | 106,771,000 | 91,554,000 | 83,961,000 | 81,447,000 | 63,613,000 | 40,203,000 | 31,789,000 | 33,676,000 | 31,345,000 | 24,661,000 | 21,390,000 | 22,176,000 | 19,120,000 | 16,853,000 | 14,876,000 | 14,437,000 | 13,399,000 | 11,462,000 | 9,958,000 | 9,669,000 | 14,382,000 | 9,149,000 | 5,781,000 | 4,339,000 | 5,308,000 |
| other liabilities | 664,000 | 680,000 | 3,635,000 | 3,579,000 | 3,526,000 | 3,485,000 | 6,249,000 | 6,186,000 | 6,079,000 | 5,983,000 | 8,832,000 | 8,664,000 | 8,526,000 | 7,680,000 | 745,000 | 484,000 | 514,000 | 448,000 | 524,000 | 545,000 | 582,000 | 672,000 | 1,828,000 | 1,844,000 | 1,899,000 | 1,772,000 | 2,505,000 | 691,000 | 720,000 | 1,776,000 | ||||||||||
| total liabilities | 367,348,000 | 216,732,000 | 206,338,000 | 217,698,000 | 221,112,000 | 238,549,000 | 262,228,000 | 270,686,000 | 276,603,000 | 282,691,000 | 317,073,000 | 319,969,000 | 322,925,000 | 335,699,000 | 349,606,000 | 338,981,000 | 329,157,000 | 324,938,000 | 330,411,000 | 125,514,000 | 51,877,000 | 43,784,000 | 47,711,000 | 40,842,000 | 34,547,000 | 31,978,000 | 34,966,000 | 20,927,000 | 18,765,000 | 17,877,000 | 15,648,000 | 14,604,000 | 12,679,000 | 11,229,000 | 10,995,000 | 15,749,000 | 9,897,000 | 6,383,000 | 4,572,000 | 5,506,000 |
| stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at june 30, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2025 and december 31, 2024; 50,389 and 49,549 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively | 5,000 | |||||||||||||||||||||||||||||||||||||||
| additional paid-in capital | 1,211,361,000 | 1,201,020,000 | 1,192,536,000 | 1,182,956,000 | 1,171,894,000 | 1,162,267,000 | 1,021,214,000 | 1,012,667,000 | 996,239,000 | 984,986,000 | 973,145,000 | 963,694,000 | 951,412,000 | 939,570,000 | 928,095,000 | 917,950,000 | 905,346,000 | 895,079,000 | 667,181,000 | 658,224,000 | 648,729,000 | 638,588,000 | 627,810,000 | 619,386,000 | 610,891,000 | 602,425,000 | 592,580,000 | 582,249,000 | 386,110,000 | 378,954,000 | 371,497,000 | 366,960,000 | 363,393,000 | 350,047,000 | 276,354,000 | 274,349,000 | 272,476,000 | 270,711,000 | 269,144,000 | 268,275,000 |
| accumulated other comprehensive loss | -750,000 | -762,000 | -741,000 | -582,000 | -2,266,000 | -3,229,000 | -4,429,000 | -7,413,000 | -10,098,000 | -11,622,000 | -15,401,000 | -18,256,000 | -14,763,000 | -11,950,000 | -2,569,000 | -1,285,000 | -1,255,000 | -1,368,000 | -59,000 | -720,000 | -874,000 | -771,000 | -903,000 | -715,000 | -553,000 | -646,000 | -572,000 | -33,000 | -719,000 | -26,000 | ||||||||||
| accumulated deficit | -996,937,000 | -926,066,000 | -932,149,000 | -880,963,000 | -821,366,000 | -768,377,000 | -705,047,000 | -642,158,000 | -580,290,000 | -508,229,000 | -441,553,000 | -381,618,000 | -306,134,000 | -237,955,000 | -161,232,000 | -455,255,000 | -396,850,000 | -339,211,000 | -289,072,000 | -242,831,000 | -251,622,000 | -217,860,000 | -177,822,000 | -151,358,000 | -116,774,000 | -115,317,000 | -83,016,000 | -87,322,000 | -68,120,000 | -78,714,000 | -187,756,000 | -171,759,000 | -151,053,000 | -136,580,000 | -114,587,000 | -94,979,000 | -76,825,000 | -62,388,000 | -51,620,000 | -46,444,000 |
| total stockholders’ equity | 213,679,000 | 274,197,000 | 259,651,000 | 301,416,000 | 348,267,000 | 390,666,000 | 311,742,000 | 363,100,000 | 405,855,000 | 465,139,000 | 516,195,000 | 563,824,000 | 630,519,000 | 689,669,000 | 764,298,000 | 461,414,000 | 507,245,000 | 554,504,000 | 377,753,000 | 415,660,000 | 397,861,000 | 420,152,000 | 450,197,000 | 468,395,000 | 494,592,000 | 487,053,000 | 508,848,000 | 494,057,000 | 317,222,000 | 299,340,000 | 183,029,000 | 194,651,000 | 211,697,000 | 212,898,000 | 161,737,000 | 180,226,000 | 196,175,000 | 208,601,000 | 216,808,000 | 221,808,000 |
| total liabilities and stockholders’ equity | 581,027,000 | 490,929,000 | 465,989,000 | 519,114,000 | 569,379,000 | 629,215,000 | 573,970,000 | 633,786,000 | 682,458,000 | 747,830,000 | 833,268,000 | 883,793,000 | 953,444,000 | 1,025,368,000 | 1,113,904,000 | 800,395,000 | 836,402,000 | 879,442,000 | 708,164,000 | 541,174,000 | 449,738,000 | 463,936,000 | 497,908,000 | 509,237,000 | 529,139,000 | 519,031,000 | 543,814,000 | 514,984,000 | 335,987,000 | 317,217,000 | 198,677,000 | 209,255,000 | 224,376,000 | 224,127,000 | 172,732,000 | 195,975,000 | 206,072,000 | 214,984,000 | ||
| liability related to sale of future royalties | 42,560,000 | 34,309,000 | 26,697,000 | 32,100,000 | 38,615,000 | 50,567,000 | 52,750,000 | 48,963,000 | 49,728,000 | 48,601,000 | 44,365,000 | 41,089,000 | 41,352,000 | 37,889,000 | 35,508,000 | 33,335,000 | 28,807,000 | 18,794,000 | ||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at march 31, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2025 and december 31, 2024; 50,117 and 49,549 shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively | 5,000 | |||||||||||||||||||||||||||||||||||||||
| commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at december 31, 2024 and 2023 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2024 and 2023; 49,549 and 44,046 shares issued and outstanding at december 31, 2024 and 2023, respectively | 5,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at september 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2024 and december 31, 2023; 49,534 and 44,046 shares issued and outstanding at september 30, 2024 and december 31, 2023, respectively | 5,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2024 and december 31, 2023; 49,317 and 44,046 shares issued and outstanding at june 30, 2024 and december 31, 2023, respectively | 5,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2024 and december 31, 2023; 49,043 and 44,046 shares issued and outstanding at march 31, 2024 and december 31, 2023, respectively | 5,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at december 31, 2023 and 2022 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2023 and 2022; 44,046 and 43,299 shares issued and outstanding at december 31, 2023 and 2022, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2023 and december 31, 2022; 43,991 and 43,299 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2023 and december 31, 2022; 43,621 and 43,299 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2023 and december 31, 2022; 43,465 and 43,299 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at december 31, 2022 and 2021 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2022 and 2021; 43,299 and 42,831 shares issued and outstanding at december 31, 2022 and 2021, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2022 and december 31, 2021; 43,292 and 42,831 shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2022 and december 31, 2021; 43,171 and 42,831 shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2022 and december 31, 2021; 42,982 and 42,831 shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at december 31, 2021 and 2020 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2021 and 2020; 42,831 and 37,476 shares issued and outstanding at december 31, 2021 and 2020, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2021 and december 31, 2020; 42,752 and 37,476 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at june 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2021 and december 31, 2020; 42,555 and 37,476 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at march 31, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2021 and december 31, 2020; 42,505 and 37,476 shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at december 31, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2020 and december 31, 2019; 37,476 and 36,992 shares issued and outstanding at december 31, 2020 and december 31, 2019, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | -360,000 | 263,000 | 750,000 | -580,000 | 205,000 | 363,000 | 471,000 | 853,000 | 521,000 | 275,000 | ||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at september 30, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2020 and december 31, 2019; 37,404 and 36,992 shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at june 30, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2020 and december 31, 2019; 37,291 and 36,992 shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at march 31, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2020 and december 31, 2019; 37,190 and 36,992 shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| deferred rent | 198,000 | |||||||||||||||||||||||||||||||||||||||
| financing lease obligations | ||||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at december 31, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2019 and december 31, 2018; 36,992 and 36,120 shares issued and outstanding at december 31, 2019 and december 31, 2018, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at september 30, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2019 and december 31, 2018; 36,840 and 36,120 shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at june 30, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2019 and december 31, 2018; 36,752 and 36,120 shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at march 31, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2019 and december 31, 2018; 36,611 and 36,120 shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| deferred rent, net of current portion | 1,098,000 | 1,116,000 | 1,192,000 | 1,225,000 | 1,211,000 | 1,205,000 | 1,217,000 | 1,271,000 | 1,326,000 | 1,367,000 | 748,000 | 602,000 | 233,000 | |||||||||||||||||||||||||||
| financing lease obligation | 5,854,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at december 31, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2018 and december 31, 2017; 36,120 and 31,295 shares issued and outstanding at december 31, 2018 and december 31, 2017, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at september 30, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2018 and december 31, 2017; 35,704 and 31,295 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively | 4,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at june 30, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2018 and december 31, 2017; 32,275 and 31,295 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at march 31, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2018 and december 31, 2017; 31,900 and 31,295 shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at december 31, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2017 and december 31, 2016; 31,295 and 26,477 shares issued and outstanding at december 31, 2017 and december 31, 2016, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at september 30, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2017 and december 31, 2016; 31,109 and 26,477 shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at june 30, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2017 and december 31, 2016; 30,853 and 26,477 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at march 31, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2017 and december 31, 2016; 30,244 and 26,477 shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| cost method investments | 300,000 | 300,000 | 300,000 | 303,000 | ||||||||||||||||||||||||||||||||||||
| advance payments | 35,000 | 127,000 | 127,000 | |||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at december 31, 2016 and december 31, 2015 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at december 31, 2016 and december 31, 2015; 26,477 and 26,313 shares issued and outstanding at december 31, 2016 and december 31, 2015, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at september 30, 2016 and december 31, 2015 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at september 30, 2016 and december 31, 2015; 26,475 and 26,313 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at june 30, 2016 and december 31, 2015 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at june 30, 2016 and december 31, 2015; 26,463 and 26,313 shares issued and outstanding at june 30, 2016 and december 31, 2015, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at march 31, 2016; no shares authorized, issued and outstanding at december 31, 2015 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 shares authorized at march 31, 2016 and december 31, 2015; 26,338 and 26,313 shares issued and outstanding at march 31, 2016 and december 31, 2015, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| trade receivables | 2,136,000 | 609,000 | ||||||||||||||||||||||||||||||||||||||
| related party receivables | ||||||||||||||||||||||||||||||||||||||||
| unbilled receivables | ||||||||||||||||||||||||||||||||||||||||
| deferred issuance costs | ||||||||||||||||||||||||||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||
| due to related party under services agreement | ||||||||||||||||||||||||||||||||||||||||
| related party promissory notes | ||||||||||||||||||||||||||||||||||||||||
| other related party payables | 349,000 | |||||||||||||||||||||||||||||||||||||||
| convertible preferred stock | ||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock; 0.0001 par value; no shares authorized, issued and outstanding at december 31, 2015; 2,393 shares authorized, issued and outstanding at december 31, 2014 | ||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock; 0.0001 par value; no shares authorized, issued and outstanding at december 31, 2015; 1,906 shares authorized, issued and outstanding at december 31, 2014 | ||||||||||||||||||||||||||||||||||||||||
| total convertible preferred stock | ||||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at december 31, 2015; no shares authorized, issued and outstanding at december 31, 2014 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 100,000 and 9,500 shares authorized at december 31, 2015 and december 31, 2014, respectively; 26,313 and 2,645 shares issued and outstanding at december 31, 2015 and december 31, 2014, respectively | 3,000 | |||||||||||||||||||||||||||||||||||||||
| total liabilities, convertible preferred stock and stockholders’ equity | 221,380,000 | 227,314,000 | ||||||||||||||||||||||||||||||||||||||
| accrued expenses | 1,727,000 | |||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock; 0.0001 par value; 2,393 shares authorized, issued and outstanding at december 31, 2014; no shares authorized, issued and outstanding at september 30, 2015 | ||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock; 0.0001 par value; 1,906 shares authorized, issued and outstanding at december 31, 2014; no shares authorized, issued and outstanding at september 30, 2015 | ||||||||||||||||||||||||||||||||||||||||
| preferred stock; 0.0001 par value; no shares authorized, issued and outstanding at december 31, 2014; 10,000 shares authorized, and no shares issued and outstanding at september 30, 2015 | ||||||||||||||||||||||||||||||||||||||||
| common stock; 0.0001 par value; 9,500 and 100,000 shares authorized at december 31, 2014 and september 30, 2015, respectively; 2,645 and 26,306 shares issued and outstanding at december 31, 2014 and september 30, 2015, respectively | 3,000 |
We provide you with 20 years of balance sheets for REGENXBIO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of REGENXBIO. Explore the full financial landscape of REGENXBIO stock with our expertly curated balance sheets.
The information provided in this report about REGENXBIO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.